+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Vacuum Assist Biopsy System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

In a Biopsy procedure tissue samples are taken for study and diagnosis of the suspicious lesions in the for cytology or histopathology studies. Breast biopsies are done through various techniques like Fine Needle Aspiration Biopsy, Core Needle Biopsy and Surgical Biopsies. Among which Fine Needle Aspiration Biopsies are the conventional ones. In case of Core Needle Biopsies tissue samples are collected through the core of the needle, this technique is currently used at many places. Vacuum Assist Biopsy is a type of core needle biopsy which uses Vacuum for collection of tissue sample. In Vacuum Assisted Biopsy the needle is introduced percutaneous to the lesion sight either by stereotactic or image assisted (Ultrasound or MRI) approach. Due to the clinical advantages of this technique for the sampling of nodular lesions, better samples combined with least procedure time, non-invasive, less scaring for patient Vacuum Assist Biopsy is gaining acceptance among the physicians. In this procedure the probe / core needle is inserted through skin under image assistance or stereotactic guidance to the lesion. One it reaches the lesion vacuum is applied which draws the lesion / tissue inside the core, after which the cutting device cuts it from the breast tissue by rotation. By repeating these steps multiple tissue samples could be collected. On required sample collection, radiologist / physician can take out the probe/needle and a small bandage can be placed on the insertion site. This procedure doesn’t need a sterile setup and is performed under local anesthesia. Due to the availability of large core probes/needles these systems are finding the place in removal of small benign lumps and resection of palpable or non-palpable breast lesions. 

Global Market for Vacuum Assist Biopsy Systems can be segmented based on the technique used for Guiding or Positioning Technique, End User and Geography:

Segmentation based on Guiding Technique

  • Stereotactic Vacuum Assist Biopsy System
  • Image Guided Vacuum Assist Biopsy System

Segmentation Based on End User

  • Hospitals
  • Clinics
  • Diagnostic Centers

Positioning and guiding of the probe / needle is the critical stage in any biopsy technique and for Vacuum Assist Biopsy it needs a skillful user. Based on the guiding technique these can be categorized into Stereotactic Vacuum Assist Biopsy Systems and Image Guided Vacuum Assist Biopsy System. For Stereotactic systems mammography is used as a reference for positioning the probe whereas image guided systems could be based on Ultrasound imaging or MRI. Among them Ultrasound guided systems are getting widely used and are having large acceptance in future. Due to some limitations like short availability of the procedure period window, difficulty in accessing the far lesions MRI guided systems got set back but with new developments they are getting acceptance for specialized procedures which are not possible with stereotactic and US guided techniques.

As this procedure is non-invasive and is undertaken with local anesthesia, it doesn’t need a complete sterile environment and so can be done in mini operating rooms or physician’s office where the MRI Guided Vacuum Assist Biopsy System is a limitation. Due to the shorter procedure time and less complications involved these procedures are done on day care basis also. Based on the End User’s the market can be segmented into Hospitals, Clinics and Diagnostic Centers.

On the basis of regional presence, global Vacuum Assist Biopsy Systems market is segmented into five key regions viz.  North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Breast Cancer counts 25% of the lethal cancers female population face and overall it contributes to around 12% of the cancer cases in a year globally. In America it is estimated that around 12% of the female population with have the breast cancer in their lifetime. In UK and Belgium around 15% of breast cancer cased are diagnosed every year. As per studies females of age more than 45 Years are susceptible to breast cancer or some breast disease. Asia Pacific region comprising countries like Indian and Chine are among the most potential markets after North America and Europe due to growing population with mid or old age and rising awareness for healthcare.

Some of the major players in global Vacuum Assist Biopsy System market are C.R. Bard Inc. Devicor Medical Products Inc.(Leica Biosystems), Hologic Inc., Etc.

The report covers exhaustive analysis on:

  • Vacuum Assist Biopsy System Market Segments
  • Vacuum Assist Biopsy System Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Vacuum Assist Biopsy System Market Size & Forecast 2016 to 2024
  • Vacuum Assist Biopsy System Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Vacuum Assist Biopsy System Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top